Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study
Davide Fiore Bavaro(Humanitas University), Annalisa Saracino(University of Bari Aldo Moro), Laura De Santis(University of Bari Aldo Moro), Deborah Fiordelisi(University of Bari Aldo Moro), Fabio Signorile(University of Bari Aldo Moro), Maria Rendina, Nicoletta Giovine(University of Bari Aldo Moro), Alessandra Belati(Humanitas University), Immacolata Attolico(Ospedale San Carlo), Vito Spada(University of Bari Aldo Moro), Lucia Diella(Humanitas University), Flavia Balena, Pellegrino Musto(University of Bari Aldo Moro), Carla Minoia(Istituto Tumori Bari), Attilio Guarini(Istituto Tumori Bari), Angelo Dargenio(University of Bari Aldo Moro), Giacomo Loseto(Istituto Tumori Bari), Michele Camporeale(University of Bari Aldo Moro), Gaetano Brindicci(University of Bari Aldo Moro), Tommasina Perrone, Crescenza Pasciolla(Istituto Tumori Bari), Simona Simone(University of Bari Aldo Moro), Francesco Di Gennaro(University of Bari Aldo Moro), Maria Dell’Aera(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Loreto Gesualdo(Unknown), Giuliana Metrangolo(University of Bari Aldo Moro), Alfredo Di Leo(University Gastroenterology)
Cited by 13
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
|Kidney International|2014|506